Terms: = Sarcomas AND DUX4L1, DUX4, P0CJ90, P0CJ89, P0CJ88, P0CJ86, P0CJ85, 22947 AND Treatment
26 results:
1. KDM2B-Rearranged Soft Tissue sarcomas Expand the Concept of BCOR-Associated Sarcoma.
Motoi T; Hirata M; Kukita Y; Satomi K; Tamura H; Adachi S; Matsushita Y; Horiguchi SI; Hishima T; Ikegami M; Okuma T; Tao K; Arakawa A; Ogawa C; Matsuda K; Ichimura K; Nakamura H; Mori T; Yoshida A
Mod Pathol; 2023 Nov; 36(11):100317. PubMed ID: 37634866
[TBL] [Abstract] [Full Text] [Related]
2. Clinical characteristics and outcomes for children, adolescents and young adults with "CIC-fused" or "BCOR-rearranged" soft tissue sarcomas: A multi-institutional European retrospective analysis.
Sparber-Sauer M; Corradini N; Affinita MC; Milano GM; Pierron G; Carton M; Tirode F; Pissaloux D; Alaggio R; Vokuhl C; Bisogno G; Berlanga P; Ferrari A; Orbach D
Cancer Med; 2023 Jul; 12(13):14346-14359. PubMed ID: 37212486
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological features of five cases of CIC::dux4 positive sarcomas, including literature review.
Rekhi B; Rumdee R; Shetty O
Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753
[TBL] [Abstract] [Full Text] [Related]
4. Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors.
Isoyama S; Tamaki N; Noguchi Y; Okamura M; Yoshimatsu Y; Kondo T; Suzuki T; Yaguchi SI; Dan S
Cell Death Dis; 2023 Feb; 14(2):169. PubMed ID: 36849535
[TBL] [Abstract] [Full Text] [Related]
5. A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl).
Palmerini E; Gambarotti M; Italiano A; Nathenson MJ; Ratan R; Dileo P; Provenzano S; Jones RL; DuBois SG; Martin-Broto J; de Alava E; Baldi GG; Grignani G; Ferraresi V; Brunello A; Paoluzzi L; Bertulli R; Hindi N; Montemurro M; Rothermundt C; Cocchi S; Salguero-Aranda C; Donati D; Martin JD; Abdelhamid Ahmed AH; Mazzocca A; Carretta E; Cesari M; Pierini M; Righi A; Sbaraglia M; Laginestra MA; Scotlandi K; Dei Tos AP; Ibrahim T; Stacchiotti S; Vincenzi B
Eur J Cancer; 2023 Apr; 183():11-23. PubMed ID: 36791667
[TBL] [Abstract] [Full Text] [Related]
6. Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group.
Brahmi M; Gaspar N; Gantzer J; Toulmonde M; Boudou-Rouquette P; Bompas E; Firmin N; Valentin T; Cancel M; Duffaud F; Bertucci F; Perrin C; Dufresne A; Marec-Bérard P; Jean-Denis M; Ray-Coquard I; Le Loarer F; Pierron G; Tirode F; Blay JY; Watson S
Cancer Med; 2023 Apr; 12(7):7801-7807. PubMed ID: 36537582
[TBL] [Abstract] [Full Text] [Related]
7. A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
Attia S; Bolejack V; Ganjoo KN; George S; Agulnik M; Rushing D; Loggers ET; Livingston MB; Wright J; Chawla SP; Okuno SH; Reinke DK; Riedel RF; Davis LE; Ryan CW; Maki RG
Cancer Med; 2023 Jan; 12(2):1532-1539. PubMed ID: 35950293
[TBL] [Abstract] [Full Text] [Related]
8. CIC-dux4 sarcomas.
Brahmi M; Vanacker H; Macagno N; Tirode F; Dufresne A
Curr Opin Oncol; 2022 Jul; 34(4):342-347. PubMed ID: 35730520
[TBL] [Abstract] [Full Text] [Related]
9. Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review.
Connolly EA; Bhadri VA; Wake J; Ingley KM; Lewin J; Bae S; Wong DD; Long AP; Pryor D; Thompson SR; Strach MC; Grimison PS; Mahar A; Bonar F; Maclean F; Hong A
Cancer Med; 2022 Apr; 11(8):1805-1816. PubMed ID: 35178869
[TBL] [Abstract] [Full Text] [Related]
10. Distinct histologic and genetic characteristics of round cell sarcoma with CIC-dux4 fusion and comparison with ewing sarcoma.
Song MJ; Cho KJ; Kim TI; Kim W; Song JS
Pathol Res Pract; 2022 Mar; 231():153779. PubMed ID: 35151033
[TBL] [Abstract] [Full Text] [Related]
11. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract] [Full Text] [Related]
12. A Rare Case of Round Cell Sarcoma with CIC-dux4 Mutation Mimicking a Phlegmon: Review of Literature.
Donthi D; Malik P; Prenshaw KL; Hong H
Am J Case Rep; 2020 Sep; 21():e925683. PubMed ID: 32873768
[TBL] [Abstract] [Full Text] [Related]
13. Imaging features and clinical course of undifferentiated round cell sarcomas with CIC-dux4 and BCOR-CCNB3 translocations.
Brady EJ; Hameed M; Tap WD; Hwang S
Skeletal Radiol; 2021 Mar; 50(3):521-529. PubMed ID: 32840647
[TBL] [Abstract] [Full Text] [Related]
14. Undifferentiated small round cell sarcoma in a young male: a case report.
Ricker CA; Berlow NE; Crawford KA; Georgopapadakos T; Huelskamp AN; Woods AD; Dhimolea E; Ramkissoon SH; Spunt SL; Rudzinski ER; Keller C
Cold Spring Harb Mol Case Stud; 2020 Feb; 6(1):. PubMed ID: 32014859
[No Abstract] [Full Text] [Related]
15. Undifferentiated round cell sarcomas with CIC-dux4 gene fusion: expanding the clinical spectrum.
Brčić I; Brodowicz T; Cerroni L; Kashofer K; Serbanescu GL; Kasseroler MT; Amann G; Scheipl S; Szkandera J; Leithner A; Liegl-Atzwanger B
Pathology; 2020 Feb; 52(2):236-242. PubMed ID: 31870501
[TBL] [Abstract] [Full Text] [Related]
16. Update on selected advances in the immunohistochemical and molecular genetic analysis of soft tissue tumors.
Thway K; Folpe AL
Virchows Arch; 2020 Jan; 476(1):3-15. PubMed ID: 31701221
[TBL] [Abstract] [Full Text] [Related]
17. Establishment of a novel human CIC-DUX
Nakai S; Yamada S; Outani H; Nakai T; Yasuda N; Mae H; Imura Y; Wakamatsu T; Tamiya H; Tanaka T; Hamada K; Tani A; Myoui A; Araki N; Ueda T; Yoshikawa H; Takenaka S; Naka N
Sci Rep; 2019 Nov; 9(1):15812. PubMed ID: 31676869
[TBL] [Abstract] [Full Text] [Related]
18. CIC-dux4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs.
Okimoto RA; Wu W; Nanjo S; Olivas V; Lin YK; Ponce RK; Oyama R; Kondo T; Bivona TG
J Clin Invest; 2019 Jul; 129(8):3401-3406. PubMed ID: 31329165
[TBL] [Abstract] [Full Text] [Related]
19. dux4 Pathological Expression: Causes and Consequences in Cancer.
Dib C; Zakharova V; Popova E; Kiseleva E; Chernyak B; Lipinski M; Vassetzky YS
Trends Cancer; 2019 May; 5(5):268-271. PubMed ID: 31174839
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathologic Features of a Series of Primary Renal CIC-rearranged sarcomas With Comprehensive Molecular Analysis.
Mangray S; Kelly DR; LeGuellec S; Fridman E; Aggarwal S; Shago M; Matoso A; Madison R; Pramanik S; Zhong S; Li R; Lombardo KA; Cramer S; Pressey J; Ross JS; Corona RJ; Bratslavsky G; Argani P; Coindre JM; Somers GR; Ali SM; Yakirevich E
Am J Surg Pathol; 2018 Oct; 42(10):1360-1369. PubMed ID: 29901569
[TBL] [Abstract] [Full Text] [Related]
[Next]
